Presatovir

TypeName: Business Offer

Category:

Offer Date:2019/07/13

Country: United States

Summary: Presatovir is a viral fusion protein inhibitor with EC50 value of 0.43 nM. It can inhibit a broad range of respiratory syncytial virus clinical isolates by blocking the virus-cell fusion process. It can also inhibit pre- to post-fusion conformational changes of the respiratory syncytial virus fusion protein. Phase II clinical trials for the treatment of respiratory syncytial virus infections is ongoing.https://www.bocsci.com/presatovir-cas-1353625-73-6-item-475346.html

Description:

OfferId: 4878

Name:Alex Brown

Telphone:

Email:[email protected]

No Man

Presatovir

Advertising